Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional steroid injections can effectively treat calcinosis and ulcers in scleroderma.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Cutaneous lymphocytosis in cats is a slowly progressing, relatively benign disease affecting older cats, often causing skin lesions and systemic signs.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Skin reactions from cancer treatments might predict how well the treatments work.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Various treatments can improve the appearance of the brow and upper lid by stimulating collagen.

PEVs effectively deliver minoxidil through skin.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Early scar classification in lupus can improve treatment and patient outcomes.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

KLF4 is important for maintaining skin stem cells and helps heal wounds.

Skin lymphatic vessels are essential for hair growth.